125 studies found for:
pituitary tumor
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Recruiting |
Evaluation of Patients With Thyroid Disorders
|
||||
| 22 | Active, not recruiting |
Barrow Nasal Inventory Survey
|
||||
| 23 | Recruiting |
The Treatment and Natural History of Acromegaly
|
||||
| 24 | Enrolling by invitation |
Rhinological Outcomes in Endonasal Pituitary Surgery
|
||||
| 25 | Recruiting |
Proton Radiation Therapy for Pituitary Adenoma
|
||||
| 26 | Terminated |
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
|
||||
| 27 | Completed |
Effect of 5 Years of GH Replacement on Atherosclerosis
|
||||
| 28 | Recruiting |
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
|
||||
| 29 | Recruiting |
A Prospective Study of Outcome After Therapy for Acromegaly
|
||||
| 30 | Recruiting |
Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities
|
||||
| 31 | Completed |
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
|
||||
| 32 | Completed |
Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders
|
||||
| 33 | Active, not recruiting |
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
|
||||
| 34 | Completed |
Evaluation of Factors in Human Brain Tumors
|
||||
| 35 | Completed |
Sandostatin LAR Depot vs. Surgery for Treating Acromegaly
|
||||
| 36 | Withdrawn |
Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas
|
||||
| 37 | Unknown † |
Antineoplaston Therapy in Treating Patients With Brain Tumors
|
||||
| 38 | Recruiting |
Forces During Skull Base Surgery
|
||||
| 39 | Active, not recruiting |
Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome
|
||||
| 40 | Completed |
Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women
|
† Indicates status has not been verified in more than two years

